1.Knight, D. J. and K. J. Girling, Gut flora in health and disease. Lancet, 2003. 361(9371): p. 1831.
2.Donskey, C. J., The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clin Infect Dis, 2004. 39(2): p. 219–26.
3.Blaut, M., Ecology and physiology of the intestinal tract. Curr Top Microbiol Immunol, 2013. 358: p. 247–72.
4.Rakoff-Nahoum, S., et al., Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell, 2004. 118(2): p. 229–41.
5.Backhed, F., et al., The gut microbiota as an environmental factor that regulates fat storage. Proceedings of the National Academy of Sciences of the United States of America, 2004. 101(44): p. 15718–15723.
6.Stappenbeck, T. S., L. V. Hooper, and J. I. Gordon, Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci U S A, 2002. 99(24): p. 15451–5.
7.Geva-Zatorsky, N., et al., Mining the Human Gut Microbiota for Immunomodulatory Organisms. Cell, 2017. 168(5): p. 928–943 e11.
8.Festi, D., et al., Gut microbiota and its pathophysiology in disease paradigms. Dig Dis, 2011. 29(6): p. 518–24.
9.Aron-Wisnewsky, J., J. Dore, and K. Clement, The importance of the gut microbiota after bariatric surgery. Nat Rev Gastroenterol Hepatol, 2012. 9(10): p. 590–8.
10.Hakansson, A. and G. Molin, Gut microbiota and inflammation. Nutrients, 2011. 3(6): p. 637–82.
11.Whorwell, P. J., et al., Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol, 2006. 101(7): p. 1581–90.
12.DuPont, H. L., et al., Pathogenesis of Escherichia coli diarrhea. N Engl J Med, 1971. 285(1): p. 1–9.
13.Barroso-Batista, J., J. Demengeot, and I. Gordo, Adaptive immunity increases the pace and predictability of evolutionary change in commensal gut bacteria. Nat Commun, 2015. 6: p. 8945.
14.Ng, S. C., et al., Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet, 2017.
15.Wotherspoon, A. C., et al., Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet, 1991. 338(8776): p. 1175–6.
16.Suzuki, H. and H. Mori, Helicobacter pylori: Helicobacter pylori gastritis—a novel distinct disease entity. Nat Rev Gastroenterol Hepatol, 2015. 12(10): p. 556–7.
17.Malfertheiner, P., F. K. Chan, and K. E. McColl, Peptic ulcer disease. Lancet, 2009. 374(9699): p. 1449–61.
18.Malfertheiner, P., et al., Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report. Gut, 2012. 61(5): p. 646–64.
19.Luo, R., et al., SOAPdenovo2: an empirically improved memory-efficient short-read de novo assembler. Gigascience, 2012. 1(1): p. 18.
20.Qin, N., et al., Alterations of the human gut microbiome in liver cirrhosis. Nature, 2014. 513(7516): p. 59–64.
21.Scher, J. U., et al., Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife, 2013. 2: p. e01202.
22.Lewis, K., Persister cells. Annu Rev Microbiol, 2010. 64: p. 357–72.
23.Hansson, G. C. and M. E. Johansson, The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Gut Microbes, 2010. 1(1): p. 51–54.
24.Sommer, F. and F. Backhed, The gut microbiota—masters of host development and physiology. Nat Rev Microbiol, 2013. 11(4): p. 227–38.
25.Word, C. J., S. S. Crago, and T. B. Tomasi, Regulation of IgA expression by isotype-specific T cells and soluble binding factors. Annu Rev Microbiol, 1986. 40: p. 503–24.
26.Dzidic, M., et al., Aberrant IgA responses to the gut microbiota during infancy precede asthma and allergy development. J Allergy Clin Immunol, 2017. 139(3): p. 1017–1025 e14.
27.Bonder, M. J., et al., The effect of host genetics on the gut microbiome. Nat Genet, 2016. 48(11): p. 1407–1412.
28.Shelburne, S. A., et al., Streptococcus mitis strains causing severe clinical disease in cancer patients. Emerg Infect Dis, 2014. 20(5): p. 762–71.
29.Costea, P. I., et al., Enterotypes in the landscape of gut microbial community composition. Nat Microbiol, 2018. 3(1): p. 8–16.
30.Prashant, G. M., et al., The effect of mango and neem extract on four organisms causing dental caries: Streptococcus mutans, Streptococcus salivavius, Streptococcus mitis, and Streptococcus sanguis: an in vitro study. Indian J Dent Res, 2007. 18(4): p. 148–51.
31.Lowy, F. D., et al., Penicillin therapy of experimental endocarditis induced by tolerant Streptococcus sanguis and nontolerant Streptococcus mitis. Antimicrob Agents Chemother, 1983. 23(1): p. 67–73.
32.Ochiai, K., et al., Effect of co-aggregation on the pathogenicity of oral bacteria. J Med Microbiol, 1993. 39(3): p. 183–90.
33.Kanehisa, M., et al., The KEGG resource for deciphering the genome. Nucleic Acids Res, 2004. 32(Database issue): p. D277–80.
34.Higgins, C. F., ABC transporters: physiology, structure and mechanism—an overview. Res Microbiol, 2001. 152(3–4): p. 205–10.
35.Radkov, A.D. and L. A. Moe, Bacterial synthesis of D-amino acids. Appl Microbiol Biotechnol, 2014. 98(12): p. 5363–74.
36.Ducker, G. S. and J. D. Rabinowitz, One-Carbon Metabolism in Health and Disease. Cell Metab, 2017. 25(1): p. 27–42.
37.Koh, A., et al., Microbially Produced Imidazole Propionate Impairs Insulin Signaling through mTORC1. Cell, 2018. 175(4): p. 947–961 e17.